Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study

Objective To determine the real world risk of gastrointestinal bleeding associated with the use of the novel oral anticoagulants dabigatran and rivaroxaban compared with warfarin. Design Retrospective, propensity matched cohort study. Setting: Optum Labs Data Warehouse, a large database including ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Abraham, Neena S, Singh, Sonal, Alexander, G Caleb, Heien, Herbert, Haas, Lindsey R, Crown, William, Shah, Nilay D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413863/
https://www.ncbi.nlm.nih.gov/pubmed/25910928
http://dx.doi.org/10.1136/bmj.h1857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413863/
https://www.ncbi.nlm.nih.gov/pubmed/25910928
http://dx.doi.org/10.1136/bmj.h1857

Ejemplares similares